glp-1 receptor agonists alternatives to ozempic How medications are transforming diabetes and weight loss treatment You might know them as

2 Influencing factors of GLP-1 secretion GLP-1 is secreted by intestinal L cells and plays a key role in the regulation of blood glucose in a glucose-dependent manner (Zhang et al., 2023)

GLP1 receptor agonists (GLP-1s) are prescription drugs widely used to manage type 2 diabetes, obesity and related chronic conditions such as cardiovascular disease and fatty liver disease

Standard therapeutic doses for diabetes typically range from 0.5 mg to 2 mg weekly for semaglutide (with Wegovy dosing up to 2.4 mg weekly for obesity), though lower doses are used during initial titration to minimize gastrointestinal side effects

GLP-1 drugs like Ozempic are usually covered for type 2 diabetes

Int J Mol Sci (2013) 14(11):2151324

Its dosage is escalated every 4 weeks